Pediatric melanoma: Confirming the diagnosis with sentinel node biopsy

Annals of Plastic Surgery

Volumn 46, Issue 4, 2001, Pages 394-399

  Zuckerman, Randall ^a   Maier, Joel P ^a   Guiney Jr , William B ^a   Huntsman, W Thomas ^a   Mooney, Eric K ^a,b  

^a BASSETT HEALTHCARE   (United States)

^b Division of Plastic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADJUVANT THERAPY; ADOLESCENT; ARTICLE; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MALE; MELANOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE;

EID: 0035046404     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-200104000-00007     Document Type: Article

References (42)

1. Malignant melanoma in children
2. Differences in malignant melanoma between children and adolescents
3. Melanoma in children
4. Malignant melanoma in childhood
5. Melanoma, melanocytic nevi, and other melanoma risk factors in children
6. Melanoma in children
7. Malignant melanoma in children and young adults: Effect of diagnostic criteria on staging and end results
8. Malignant melanoma in childhood and adolescence
9. Melanomas of childhood
10. Melanocytic tumors
11. Primary mesenchymal tumors
12. Malignant melanoma in childhood: A clinicopathologic study of 13 cases and comparison with Spitz nevi
13. Spindle cell epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus)
14. Cutaneous melanoma and atypical Spitz tumors in childhood
15. Tumors of neural tissue
16. Current therapy of cutaneous melanoma
17. Elective lymph node dissection: Pros and cons
18. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
19. Lymphatic drainage of skin to sentinel lymph node in a feline model
20. Symposium. Lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma - Part 1
21. Symposium. Lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma - Part 2
22. Lymphatic mapping and selective lymphadenectomy as an alternative to elective lymph node dissection in patients with malignant melanoma
23. Technical details of intraoperative lymphatic mapping for early stage melanoma
24. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes
25. Single-injection gamma probe-guided sentinel lymph node detection in 40 melanomatous lymphadenectomies
26. Melanoma nodal metastases
27. Multiinstitutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
28. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma
29. Re: Sentinel lymph node mapping in melanoma of the ear
30. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial. WHO melanoma programme
31. Immunotherapy and experimental approaches for metastatic melanoma
32. Issues in the epidemiology of melanoma
33. Adjuvant therapy of malignant melanoma
34. Adjuvant therapy for melanoma
35. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases
36. Adjuvant interferon treatment for melanoma
37. Results of interleukin-2-based treatment in advanced melanoma: A case record-based analysis of 631 patients
38. Vaccines and other adjuvant therapies for melanoma
39. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
40. Preliminary analysis of the E1690/C9190 intergroup postoperative adjuvant trial of high and low dose interferon-2b (HDI and IDI) in high risk primary or lymph node metastatic melanoma